Hanoi (VNA) – The Ministry of Health (MoH) has urged Nanogen Biopharmaceutical Co. Ltd. to complete procedures to promptly carry out COVID-19 vaccine testing on humans in November.
Human trials of “made-in-Vietnam” COVID-19 vaccine developed by Nanogen Biopharmaceutical might be implemented soon following the completion of paperwork, said Nguyen Ngo Quang, Vice Director of the MoH’s Administration of Science, Technology and Training on November 3.
The first phase expects to conduct tests on a group of 20 volunteers, while the second phase will involve 600 people and the third phase, 10,000 people.
If successful, the vaccine, which is being tested on animals, will be the first one in Vietnam to have human trials.
Nanogen Biopharmaceutical is capable of producing about 30 million doses of vaccine annually, meeting domestic demands.
The vaccine developed by Nanogen Biopharmaceutical is now one of the two most potential vaccines in Vietnam.
In late October, a vaccine developed by the Vaccine and Biological Production Company (Vabiotech) under the MoH was tested on monkeys. The results of the testing will be a foundation for the next stage and proposal to test the vaccine on people.
In June 2020, Vabiotech tested the vaccine on mice./.
